The expression and prognostic significance of hepatoma-derived growth factor in oral cancer

Oral Oncology

Volumn 48, Issue 7, 2012, Pages 629-635

  Lin, Yu Wei ^a,b   Li, Chien Feng ^a,b   Chen, Hsuan Yu ^b   Yen, Ching Yu ^a,d   Lin, Li Ching ^a   Huang, Chao Cheng ^c   Huang, Hsuan Ying ^c   Wu, Ping Ching ^e   Chen, Chang Han ^c   Chen, San Cher ^b   Tai, Ming Hong ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Head and neck cancer; Hepatoma derived growth factor (HDGF); Local recurrence free survival; Oral cancer; Tumor necrosis

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; HEPATOMA DERIVED GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENICITY; CELL LINE; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR NECROSIS;

ADULT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862815908     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.01.014     Document Type: Article

References (30)

1. G.F. Funk, L.H. Karnell, R.A. Robinson, W.K. Zhen, D.K. Trask, and H.T. Hoffman Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report Head Neck 24 2002 165 180 (Pubitemid 34111514)
2. J.N. Al-Swiahb, C.H. Chen, H.C. Chuang, F.M. Fang, H.T. Tasi, and C.Y. Chien Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity Future Oncol 6 2010 837 850
3. F.R. Khuri, D.M. Shin, B.S. Glisson, S.M. Lippman, and W.K. Hong Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions Semin Oncol 27 2000 25 33 (Pubitemid 30643362)
4. Z. Zhou, Y. Yamamoto, and F. Sugai Hepatoma-derived growth factor is a neurotrophic factor harbored in the nucleus J Biol Chem 279 2004 27320 27326 (Pubitemid 38812572)
5. A.D. Everett, T. Stoops, and C.A. McNamara Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells J Biol Chem 276 2001 37564 37568
6. H. Enomoto, K. Yoshida, and Y. Kishima Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation Hepatology 36 2002 1519 1527 (Pubitemid 35403542)
7. J.A. Oliver, and Q. Al-Awqati An endothelial growth factor involved in rat renal development J Clin Invest 102 1998 1208 1219 (Pubitemid 28436281)
8. A.D. Everett, D.R. Lobe, M.E. Matsumura, H. Nakamura, and C.A. McNamara Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development J Clin Invest 105 2000 567 575 (Pubitemid 30146503)
9. T.H. Hu, C.C. Huang, and L.F. Liu Expression of hepatoma-derived growth factor in hepatocellular carcinoma Cancer 98 2003 1444 1456
10. K. Yoshida, Y. Tomita, and Y. Okuda Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma Ann Surg Oncol 13 2006 159 167 (Pubitemid 43157409)
11. H. Ren, X. Tang, and J.J. Lee Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer J Clin Oncol 22 2004 3230 3237 (Pubitemid 41103677)
12. S. Yamamoto, Y. Tomita, and Y. Hoshida Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma Clin Cancer Res 12 2006 117 122 (Pubitemid 43166184)
13. A. Matsuyama, H. Inoue, and K. Shibuta Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer Cancer Res 61 2001 5714 5717 (Pubitemid 32769083)
14. S. Yamamoto, Y. Tomita, and Y. Hoshida Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma Ann Surg Oncol 14 2007 2141 2149 (Pubitemid 46988256)
15. K.C. Chang, M.H. Tai, and J.W. Lin Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors Int J Cancer 121 2007 1059 1065
16. P.S. Yoo, C.A. Sullivan, and S. Kiang Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival Ann Surg Oncol 16 2009 200 207
17. S.H. Li, C.F. Li, and M.T. Sung Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray Mod Pathol 20 2007 497 507
18. Y.H. Kao, C.L. Chen, and B. Jawan Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis J Hepatol 52 2010 96 105
19. G.S. Liu, H.E. Tsai, and W.T. Weng Systemic pro-opiomelanocortin expression induces melanogenic differentiation and inhibits tumor angiogenesis in established mouse melanoma Hum Gene Ther 22 2011 325 335
20. M. Brandwein-Gensler, M.S. Teixeira, and C.M. Lewis Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival Am J Surg Pathol 29 2005 167 178 (Pubitemid 40170634)
21. D. Kademani, R.B. Bell, and S. Bagheri Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade J Oral Maxillofac Surg 63 2005 1599 1605 (Pubitemid 41525416)
22. H. Hiratsuka, A. Miyakawa, K. Nakamori, Y. Kido, H. Sunakawa, and G. Kohama Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity Cancer 80 1997 351 356 (Pubitemid 27323403)
23. R.E. Cilley, S.E. Zgleszewski, and M.R. Chinoy Fetal lung development: airway pressure enhances the expression of developmental genes J Pediatr Surg 35 2000 113 118 [discussion 9]
24. M. Lepourcelet, L. Tou, and L. Cai Insights into developmental mechanisms and cancers in the mammalian intestine derived from serial analysis of gene expression and study of the hepatoma-derived growth factor (HDGF) Development 132 2005 415 427 (Pubitemid 40268290)
25. J. Yang, and A.D. Everett Hepatoma-derived growth factor binds DNA through the N-terminal PWWP domain BMC Mol Biol 8 2007 101
26. P.D. Gottlieb, S.A. Pierce, and R.J. Sims Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis Nat Genet 31 2002 25 32
27. J. Yang, and A.D. Everett Hepatoma-derived growth factor represses SET and MYND domain containing 1 gene expression through interaction with C-terminal binding protein J Mol Biol 386 2009 938 950
28. E. Winquist, T. Oliver, and R. Gilbert Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic ressview with meta-analysis Head Neck 29 2007 38 46 (Pubitemid 46032565)
29. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
30. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944